Business
MedMira Appoints David Slauenwhite Chief Financial Officer
HALIFAX, Sept. 16 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a develope...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nHALIFAX, Sept. 16 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostics, announced today\nthe appointment of David Slauenwhite as Chief Financial Officer.\nMr. Slauenwhite comes to MedMira with over 20 years of experience in the\nglobal arena.\n\n\n"We are pleased to welcome David to MedMira," said Hermes Chan, President\n& CEO, MedMira Inc. "His wealth of knowledge and experience, coupled with his\nexpertise in international markets and business models, will be of significant\nbenefit to us, as MedMira advances forward with its strategic growth plan."\n\n\nMr. Slauenwhite was formerly based in Calgary, AB where he held various\nsenior financial and management roles in the manufacturing, industrial, and\nengineering sectors. He has an exceptionally strong skill set in raising\ncapital, managing resources across all business functions, corporate\ngovernance, and strategic expansion through sales growth, mergers and\nacquisitions.\n\n\n"MedMira is on the threshold of significant growth. The Company's\ncommitment to quality and innovation, and the dedicated, passionate management\nteam, is what attracted me to this role," said Mr. Slauenwhite.\n\n\nMr. Slauenwhite is a graduate of St. Mary's University, Halifax, Nova\nScotia and The Institute of Chartered Accountants of Nova Scotia.\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals with reliable, rapid diagnosis for diseases such as HIV and\nhepatitis C in just three minutes. The company's tests are sold under the\nReveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global\nmarkets. MedMira's rapid HIV test is the only one in the world to achieve\nregulatory approvals in Canada, the United States, China and the European\nUnion. MedMira's corporate offices and manufacturing facilities are located in\nHalifax, Nova Scotia, Canada. For more information visit MedMira's website at\nwww.medmira.com.\n\n\nThis news release contains forward-looking statements, which involve risk\nand uncertainties and reflect the company's current expectation regarding\nfuture events. Actual events could materially differ from those projected\nherein and de...